Drug Profile
Hesed 3000
Alternative Names: Hesed-3000Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Ensol Biosciences
- Class Antibacterials
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Periodontal disorders
Most Recent Events
- 12 Sep 2023 Discontinued - Preclinical for Periodontal disorders in South Korea (unspecified route) (Ensol Biosciences website, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Periodontal-disorders in South Korea
- 26 Jul 2016 Preclinical trials in Periodontal disorders in South Korea (unspecified route)